ALTERITY THERAPEUTICS-ADR

ATHE · NASDAQ

Updated at 2026-10-14 09:20:46

$2.85-2.73%
Today's High
$2.94
Today’s Low
$2.80
ALTERITY THERAPEUTICS-ADR (ATHE) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$3.07
Previous Close
$2.93
Volume
31.64K
Market Cap
$81.34M
P/E Ratio
--
EPS
$-0.11

Previous Day Range

$2.82$3.09

52-Week Range

$0.01$0.78

Company Overview

Sector
HEALTHCARE
Industry
Biotechnology
Sub-industry
BIOTECHNOLOGY
Headquarters
500 COLLINS STREET, MELBOURNE, VIC, AUSTRALIA, 3000
Country
AU
Listing Date
2000-03-28
Fiscal Year End
June
Shares Outstanding
217.69M
CIK
0001131343

Alterity Therapeutics Limited researches and develops therapeutic drugs for the treatment of Parkinson's disease and other neurodegenerative diseases in Australia. The company is headquartered in Melbourne, Australia.

Financial Metrics

Revenue

2026-06-30

--

2025-12-31

--

2025-06-30

$3.83M

2024-12-31

$1.6M

Operating Expenses

2026-06-30

$15.52M

2025-12-31

$12.76M

2025-06-30

$10.85M

2024-12-31

$9.02M

Net Income

2026-06-30

-$13.97M

2025-12-31

-$9.43M

2025-06-30

-$4.97M

2024-12-31

-$7.17M

Net Profit Margin

2026-06-30

--

2025-12-31

--

2025-06-30

-129.78%

2024-12-31

-446.67%

Earnings Per Share

2026-06-30

--

2025-12-31

--

2025-06-30

$0.00

2024-12-31

$0.00

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-06-30

-$15.52M

2025-12-31

-$12.76M

2025-06-30

-$7.04M

2024-12-31

-$7.47M

Effective Tax Rate

2026-06-30

5.19%

2025-12-31

22.18%

2025-06-30

-1.38%

2024-12-31

18.29%

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.